Semaglutide, a GLP-1 receptor agonist, and prednisone, a corticosteroid, differ significantly in their chemical structure, mechanism of action, therapeutic uses, and side effects
Patient has a BMI (body mass index) of 27 or higher and at least one weight-related health condition like diabetes, high blood pressure, heart disease, or sleep apnea
WHY PEOPLE CHOOSE RELEASE Looking for a GLP-1 alternative
GLP-1 stands for glucagon-like peptide-1, a hormone involved in appetite regulation, insulin response, digestion, and blood sugar control
once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
Semaglutide has been studied extensively for long-term use, and we carefully track your progress to ensure its supporting your health, not just your weight loss